MARKET

RDHL

RDHL

Redhill Biopharm
NASDAQ
0.8128
-0.0659
-7.50%
Opening 11:34 03/12 EDT
OPEN
0.8400
PREV CLOSE
0.8787
HIGH
0.8521
LOW
0.8000
VOLUME
50.25K
TURNOVER
--
52 WEEK HIGH
3.460
52 WEEK LOW
0.8000
MARKET CAP
4.16M
P/E (TTM)
-0.3549
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at RDHL last week (0302-0306)?
Weekly Report · 3d ago
RedHill Biopharma Shareholders Approve RSU Grants and Share Capital Increase
TipRanks · 03/05 14:32
Cumberland Pharmaceuticals 2025 revenue rises 
Reuters · 03/03 22:12
Weekly Report: what happened at RDHL last week (0223-0227)?
Weekly Report · 03/02 10:06
RedHill Biopharma announces full sales and operational launch of Talicia
TipRanks · 02/25 12:17
RedHill Biopharma Says Full Sales And Operational Launch Of Talicia, Under Joint Commercialization Agreement Between Talicia And Cumberland Pharmaceuticals Has started
Benzinga · 02/25 12:11
Cumberland Pharmaceuticals and RedHill Biopharma Co-Commercialize Talicia in U.S
Reuters · 02/25 12:01
Weekly Report: what happened at RDHL last week (0216-0220)?
Weekly Report · 02/23 10:06
More
About RDHL
RedHill Biopharma Ltd is an Israel-based specialty biopharmaceutical company primarily focused on gastrointestinal and infectious diseases. RedHill promotes the gastrointestinal drugs such as, Talicia for the treatment of Helicobacter pylori (H. pylori) infection, and Aemcolo, for the treatment of travelers’ diarrhea. RedHill’s clinical late-stage development programs include: :info: RHB-204, for pulmonary nontuberculous mycobacteria (NTM) disease; opaganib (ABC294640), host-directed, SPHK2 inhibitor targeting multiple indications, RHB-107 (upamostat), an oral, host-directed serine protease inhibitor with potential for pandemic preparedness, is in late-stage development for treatment of non-hospitalized symptomatic COVID-19, and is targeting multiple other cancer and inflammatory gastrointestinal diseases; RHB-104 for Crohn's disease; and RHB-102 for chemotherapy and radiotherapy induced nausea and vomiting.

Webull offers RedHill Biopharma Ltd (ADR) stock information, including NASDAQ: RDHL real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, RDHL stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading RDHL stock methods without spending real money on the virtual paper trading platform.